全文获取类型
收费全文 | 76706篇 |
免费 | 6419篇 |
国内免费 | 3081篇 |
专业分类
耳鼻咽喉 | 701篇 |
儿科学 | 1631篇 |
妇产科学 | 1184篇 |
基础医学 | 7822篇 |
口腔科学 | 1166篇 |
临床医学 | 7662篇 |
内科学 | 5697篇 |
皮肤病学 | 806篇 |
神经病学 | 4846篇 |
特种医学 | 4419篇 |
外国民族医学 | 52篇 |
外科学 | 14494篇 |
综合类 | 12078篇 |
现状与发展 | 19篇 |
预防医学 | 1912篇 |
眼科学 | 592篇 |
药学 | 4956篇 |
46篇 | |
中国医学 | 2201篇 |
肿瘤学 | 13922篇 |
出版年
2024年 | 89篇 |
2023年 | 1043篇 |
2022年 | 1690篇 |
2021年 | 3025篇 |
2020年 | 2601篇 |
2019年 | 2323篇 |
2018年 | 2241篇 |
2017年 | 2466篇 |
2016年 | 2720篇 |
2015年 | 2988篇 |
2014年 | 4749篇 |
2013年 | 5119篇 |
2012年 | 4249篇 |
2011年 | 4930篇 |
2010年 | 3993篇 |
2009年 | 3963篇 |
2008年 | 4013篇 |
2007年 | 4152篇 |
2006年 | 3763篇 |
2005年 | 3366篇 |
2004年 | 2896篇 |
2003年 | 2469篇 |
2002年 | 2255篇 |
2001年 | 2008篇 |
2000年 | 1701篇 |
1999年 | 1462篇 |
1998年 | 1195篇 |
1997年 | 1097篇 |
1996年 | 926篇 |
1995年 | 911篇 |
1994年 | 774篇 |
1993年 | 657篇 |
1992年 | 575篇 |
1991年 | 447篇 |
1990年 | 383篇 |
1989年 | 357篇 |
1988年 | 354篇 |
1987年 | 318篇 |
1986年 | 229篇 |
1985年 | 277篇 |
1984年 | 259篇 |
1983年 | 166篇 |
1982年 | 206篇 |
1981年 | 160篇 |
1980年 | 131篇 |
1979年 | 112篇 |
1978年 | 91篇 |
1977年 | 87篇 |
1976年 | 56篇 |
1973年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 32 毫秒
51.
Dave E. W. van der Kruijssen Auke J. S. van der Kuil Geraldine R. Vink Cornelis J. A. Punt Johannes H. W. de Wilt Sjoerd G. Elias Miriam Koopman 《International journal of cancer. Journal international du cancer》2023,152(7):1360-1369
We studied the prognostic value of primary tumor sidedness in metastatic colorectal cancer over time and across treatment lines. Population data on synchronous metastatic colorectal cancer patients were extracted from the Netherlands Cancer Registry and SEER database. Pubmed, EMBASE and Cochrane library were searched for prospective studies on metastatic colorectal cancer to conduct a meta-analysis. Inclusion criteria consisted of metastatic disease, systemic treatment with palliative intent and specification of primary tumor location. Data were pooled using a random-effects model. For the population-based data, multivariable Cox models were constructed. The Grambsch-Therneau test was conducted to evaluate the potential time-varying nature of sidedness. Meta-regression incorporating treatment-line as variable was conducted to test the pre-specified hypothesis that the prognostic value of sidedness varies over time. Analysis of 12 885 and 16 160 synchronous metastatic colorectal cancer patients registered in the Netherlands Cancer Registry and SEER database, respectively, indicated a time-varying prognostic value of sidedness (P < .01). Thirty-one studies were selected for the meta-analysis (9558 patients for overall survival analysis). Pooled univariable hazard ratioleft-sided/right-sided for overall survival was 0.71 (95% CI: 0.65-0.76) in 1st-line, 0.76 (0.54-1.06) in 2nd-line and 1.01 (0.86-1.19) in 3rd-line studies. Hazard ratios were significantly influenced by treatment line (P = .035). The prognostic value of sidedness of the primary tumor in metastatic colorectal cancer patients treated with palliative systemic therapy decreases over time since diagnosis, suggesting that sidedness may not be a useful stratification factor in late-line trials. This decrease in prognostic value should be taken into account when providing prognostic information to patients. 相似文献
52.
53.
舌癌患者手术及放化疗后会出现构音障碍、吞咽困难、口腔黏膜炎、口干、营养不良等并发症,使患者生存质量下降,甚至导致肿瘤的复发转移,影响生存期,单一方法往往顾此失彼。依托于中国中医科学院西苑医院肿瘤康复基地,杨宇飞教授在国内外调研考察基础上,结合中国国情,构建了一种“门诊多学科肿瘤康复模式”,在舌癌康复方面,以患者为中心,以中医肿瘤内科为主导,多学科共同参与,结合康复科、口腔科、营养科、药剂科等各科优势,形成全程个体化规范序贯康复方案,对患者及早进行康复,在放疗前进行预防性干预尤其重要,使患者能够快速缓解手术和放疗的不良反应,患者获益明显。现取两个典型案例总结其舌癌多学科康复的经验,以期为舌癌的康复提供借鉴。 相似文献
54.
《Clinical lung cancer》2022,23(3):191-194
BackgroundTo accelerate drug approvals while maintaining scientific rigor in the evaluation of a therapeutic's efficacy and safety, the United States Food and Drug Administration now considers real-world data (RWD) to support New Drug Applications and expanded indications. Response Evaluation Criteria in Solid Tumors (RECIST) are the gold standard in clinical trials, but the derivation of RECIST-based treatment response from RWD is unproven. This study investigated the feasibility of implementing RECIST criteria in RWD by comparing lung cancer response assessments from RECIST-based measurement of lesions on archived radiologic films with results from medical oncologist and radiologist narratives recorded in electronic health records (EHR).Materials and MethodsResponse to index treatment via different assessment approaches was compared among 30 metastatic non-small cell lung cancer (mNSCLC) patients receiving systemic treatment (index) after progression on a platinum or anti-PD(L)-1-containing regimen. Specifically, responses based on assessments documented in the medical oncologists’ narratives were compared to a radiologist's assessments of archived images using RECIST v1.1 criteria. Each patient's best overall response was characterized as complete or partial (CR/PR), stable disease (SD), progressive disease (PD), or not evaluable (NE).ResultsSimilar distributions of best overall response and substantial concordance (77%) between medical oncologist-reported and radiologist re-assessed responses were observed. There were no instances of CR/PR to PD or PD to CR/PR discordance.ConclusionsResults suggest that accurate treatment responses, similar to RECIST, may be derived using RWD. Further validation and improvement of real-world response assessment are needed to develop a scalable real-world approach for response assessment. 相似文献
55.
56.
57.
58.
59.
60.